| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $2,492,929 ) |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 5 | NIH | 12/2/2025 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH132226 | Probing brain circuit and behavior with protein:protein interaction modulators | 000 | 4 | NIH | 12/10/2025 | $794,232 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI187192 | Investigation of RNA packaging in Rift Valley fever virus | 000 | 2 | NIH | 12/5/2025 | $655,774 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 000 | 4 | NIH | 12/9/2025 | $388,626 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | DP2AI154410 | Revealing the Biophysics of the Germinal Center Microenvironment | 000 | 5 | NIH | 12/3/2025 | $480,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03AI182562 | Development of a latex-agglutination assay for the rapid detection of Naegleria fowleri | 000 | 2 | NIH | 12/3/2025 | $80,000 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY037126 | The Role of mtDNA/ZBP1 in Retinal Neurodegeneration | 000 | 1 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21DA063306 | GPR6: A Circuit-Level Druggable Target in Cocaine Use Disorder | 000 | 1 | NIH | 11/20/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R33AG078519 | Developing, Implementing, and Evaluating a Caregiver and Elder Abuse Screening, Risk Assessment and Treatment to Improve Outcomes for Older and Vulnerable Adults with MCI/ADRD | 000 | 3 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI176297 | Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases | 000 | 2 | NIH | 12/2/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI146227 | Mechanistic function of HCV NS5A targeted by the potent inhibitors | 000 | 5 | NIH | 11/24/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00DC016328 | Determining the roles of Ca2+-binding proteins in modulation of hair cell mechanotransduction | 000 | 5 | NIH | 11/25/2025 | -$351 |
| | 2026 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21ES034956 | Brain derived extracellular vesicles-mediated neurotoxicity of deltamethrin | 000 | 1 | NIH | 11/20/2025 | $0 |
| | 2026 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK106229 | Hypothalamic-Striatal Control of Motivation for Obesogenic Food | 000 | 4 | NIH | 10/1/2025 | $0 |
| | 2026 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UG3DA052282 | NOP Receptor Antagonist for OUD Pharmacotherapy | 000 | 1 | NIH | 10/1/2025 | -$206,131 |
| | 2026 | 2019 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI125434 | Hydrogen Sulfide and NRF2 Cross-talk in Viral Infections | 000 | 3 | NIH | 10/1/2025 | -$99,221 |
|
| Issue Date FY: 2025 ( Subtotal = $93,791,920 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149762 | Protein turnover estimation from fragment ions and precursor enrichment in heavy water labeled LC-MS experiments | 000 | 2 | NIH | 8/21/2025 | $372,285 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U01AI168622 | One-Health Approach to Study Human Fasciola hepatica Transmission and Inform Strategic Control | 000 | 4 | NIH | 4/25/2025 | $467,735 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01NS137812 | Tunneling nanotubes are a novel mechanism for the propagation of HIV infection and neurodegeneration | 000 | 2 | NIH | 8/8/2025 | $197,345 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01AG086589 | Informant Measures Of Cognitive Decline In Mexico | 000 | 2 | NIH | 8/21/2025 | $123,431 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01CA273001 | The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy | 000 | 2 | NIH | 8/19/2025 | $402,874 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UH3TR004117 | 3-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth | 001 | 4 | NIH | 7/29/2025 | $233,262 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI176085 | Extracellular Vesicles (EVs) Innate Immune Cargo in Respiratory Viral Infections | 000 | 2 | NIH | 3/21/2025 | $200,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R34AR084669 | Integrated spatial omics to elucidate conserved inflammatory mechanisms of vesicant-induced skin injury | 001 | 2 | NIH | 8/12/2025 | $1 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R34AR084669 | Integrated spatial omics to elucidate conserved inflammatory mechanisms of vesicant-induced skin injury | 001 | 2 | NIH | 8/12/2025 | $182,239 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG088215 | The function of post-translational modifications of myosin and its chaperone UNC-45 that occur with adult aging | 001 | 2 | NIH | 7/14/2025 | $550,655 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH134761 | Targeting cell-to-cell communication to prevent bystander damage mediated by viral reservoirs | 001 | 2 | NIH | 9/19/2025 | $103,494 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH134761 | Targeting cell-to-cell communication to prevent bystander damage mediated by viral reservoirs | 000 | 2 | NIH | 1/10/2025 | $586,466 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS131507 | The role of neuro-immune interactions in PACAP induced migraine | 000 | 2 | NIH | 1/15/2025 | $449,651 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01HL171461 | FGF21 protects from progressive metabolic syndrome after undernutrition refeeding | 000 | 2 | NIH | 8/30/2025 | $132,116 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 4 | NIH | 11/7/2024 | $400,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | RM1NS128787 | Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain | 001 | 4 | NIH | 8/4/2025 | $1,733,153 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R34MH136826 | Leveraging video logs as a bridge to pre-exposure prophylaxis (PrEP) with tailored messaging to Black women and their healthcare providers in Texas | 002 | 2 | NIH | 7/9/2025 | $11,479 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R34MH136826 | Leveraging video logs as a bridge to pre-exposure prophylaxis (PrEP) with tailored messaging to Black women and their healthcare providers in Texas | 002 | 2 | NIH | 7/9/2025 | $325,747 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034616 | Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina | 000 | 3 | NIH | 4/11/2025 | $541,883 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI184781 | Pre-clinical studies to repurpose FDA-approved adenosine A2A receptor antagonists for lethal rickettsial infection | 000 | 1 | NIH | 6/11/2025 | $463,698 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS130839 | Regulation of HTT-mediated DNA damage repair and chromatin remodeling Complexes | 000 | 3 | NIH | 8/13/2025 | $666,180 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 001 | 3 | NIH | 8/12/2025 | $32,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM150459 | Dynamic regulatory impact of human transposable elements on gene expression | 000 | 3 | NIH | 5/19/2025 | $387,465 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 000 | 3 | NIH | 1/21/2025 | $288,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK132072 | Targeting bone marrow to treat renal disease | 000 | 3 | NIH | 12/9/2024 | $424,750 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI176297 | Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases | 000 | 2 | NIH | 12/16/2024 | $192,543 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM151324 | Dissecting the Mechanisms of Quaking-Regulated RNA Processing | 000 | 3 | NIH | 6/5/2025 | $400,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2CTR004868 | A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health | 000 | 2 | NIH | 7/17/2025 | $500,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2CTR004868 | A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health | 000 | 2 | NIH | 7/17/2025 | $996,973 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HL181469 | C type Lectin Pathway Regulates Macrophage Immune Metabolism in Mtb-Infected Lung | 000 | 1 | NIH | 8/21/2025 | $788,478 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R33AG078519 | Developing, Implementing, and Evaluating a Caregiver and Elder Abuse Screening, Risk Assessment and Treatment to Improve Outcomes for Older and Vulnerable Adults with MCI/ADRD | 000 | 3 | NIH | 9/17/2025 | $738,817 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI184534 | Human papillomavirus and risk to pregnancy: a cohort study | 000 | 1 | NIH | 9/2/2025 | $811,033 |
|
